Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04791384
Status:
RECRUITING
Last Update Posted:
2023-07-27
First Post:
2020-12-30
Brief Title:
Phase IbII Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HRHer2- Breast Cancer
Sponsor:
Criterium Inc
Organization:
Criterium Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-30
First Submit QC Date:
March 8 2021
Study First Post Date:
2021-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-25
Last Update Post Date:
2023-07-27
Last Update Post Date Type:
ACTUAL